We have pharmaceutical companies that are constantly trying to expand the indications, expand the number of people who are eligible for a given treatment, because that obviously helps their bottom line. We have advocacy groups, like the one that's come up with pre-vivor, who want to make more and more people feel they are at risk, or might have a condition, so that they can raise more funds and raise visibility, et cetera.
Hai compañías farmacéuticas que tratan constantemente de ampliar as indicacións, ampliar o número de persoas que son aptas para certos tratamentos porque obviamente isto incrementa os seus ingresos Existen grupos de apoio como os que inventaron a palabra previvente, que queren facer que as persoas sintan que están en perigo, ou que pode que padezan unha doenza para así obter máis fondos, e ser máis visibles, etcétera.